Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

2007839 citationsJournal Article

Authors

Good health and well-being

Published in: Nature Biotechnology

Volume 25, Issue 8, pp. 911-920

Field-Weighted Citation Impact: 22.89